Table 4.

Characteristics of patients (n = 10), in which 11 episodes of febrile neutropenia developed during chemotherapy cycles.

		No. of patients	Percentage (%)
Gender	Male	3	30
	Female	7	70
Age	Mean: 46.9 years (range 18–78)
Tumor subgroup	Gynecological	1	10
	Upper GI tract	2	20
	Sarcoma	4	40
	Urinary tract	1	10
	Lymphoma	1	10
	Breast	1	10
	Lower GI tract	–	–
CT-regimen	Relative low myelosuppression risk	1	10
	Relative high myelosuppression risk	9	90
CT-cycles	Mean: 2 cycles (range 1-6)
Temperature	Mean: 39.0°C (range 38.4–40.6°C)
Neutrophil count	Mean: 0.11 × 109/L (range 0.00–0.33)
Source of infection (per episode)	Urinary tract	2	18.2
	Airway	2	18.2
	Fever of unknown origin	7	63.6
Blood cultures (per episode)	Positive	1	9.1
	Negative	10	90.9
Treatment (per episode)	Intravenous antibiotics	10	90.9
	Oral antibiotics	1	9.1

GI, gastrointestinal; CT, chemotherapy.